Portrait Mobile Monitoring Solution V2.0 External Evaluation

NCT07309809 | Not Yet Recruiting

• 1 other identifier: SA-000173
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to collect and assess feedback from the users regarding the functionality and performance of the Portrait Mobile Monitoring Solution V2.0. In addition, this study aims to collect raw parameter data from the investigational devices for use in current and future Portrait Mobile development, including engineering purposes as deemed appropriate by the Sponsor.

Conditions

Monitoring

Keywords

Continuous Monitoring

Outcome Measures

Primary Outcomes (2)

• Collection of user feedback surveys from Clinicians

  Number of clinician feedback surveys collected at the end of each shift for clinicians overseeing care of subjects receiving continuous vital signs monitoring.

  Up to 72 hours

• Collection of Subject Survey

  Number of subject surveys collected from study participants at the end of their continuous monitoring

  up to 72 hours

Secondary Outcomes (1)

• Collection of raw parameter data from Portrait Mobile Device

  up to 72 hours

Study Arms (1)

Continuous Monitoring with Portrait Mobile

EXPERIMENTAL

Subjects will be monitored with the Portrait Mobile Monitoring Solution for up to 72 hours

Device: Continuous Monitoring

Interventions

Continuous Monitoring DEVICE

Subjects will have vital signs continuously monitored for up to 72 hours with the study device

Continuous Monitoring with Portrait Mobile

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participant is age 18 years or older (≥18 years).
• Participant must have the ability to understand and provide written informed consent.
• Are being cared for in a hospital unit and are expected to remain in the unit for the duration of the study procedure.
• Participant must be willing and able to comply with study procedures and duration.

You may not qualify if:

• Known to be pregnant and/or breast feeding.
• Diagnosed with infection requiring isolation.
• Are immunocompromised.
• Have previously participated in this study (no subject may participate more than once).
• Subjects with Implantable Minute Ventilation Rate Responsive Pacemakers should be excluded from respiration rate monitoring.

Sponsors & Collaborators

• GE Healthcare: lead

Study Sites (1)

West Middlesex University Hospital

London, England, TW7 6AF, United Kingdom

Location

MeSH Terms

Interventions

Continuous Glucose Monitoring

Intervention Hierarchy (Ancestors)

Blood Chemical Analysis; Clinical Chemistry Tests; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Diagnostic Techniques, Endocrine; Monitoring, Physiologic; Investigative Techniques

Central Study Contacts

Meghan Terry

CONTACT

262-290-6037; Meghan.Terry@gehealthcare.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: BASIC SCIENCE
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 3, 2025
• First Posted: December 30, 2025
• Study Start: March 1, 2026
• Primary Completion (Estimated): July 1, 2026
• Study Completion (Estimated): July 1, 2026
• Last Updated: December 30, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will not share

Locations

GB (1)